Gonadotropin treatment for male partial congenital hypogonadotropic hypogonadism in Chinese patients

来源 :亚洲男性学杂志(英文版) | 被引量 : 0次 | 上传用户:dyoyo90
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Partial congenital hypogonadotropic hypogonadism (PCHH) is caused by an insufficiency in,but not a complete lack of,gonadotropin secretion.This leads to reduced testosterone production,mild testicular enlargement,and partial pubertal development.No studies have shown the productivity of spermatogenesis in patients with PCHH.We compared the outcomes of gonadotropin-induced spermatogenesis between patients with PCHH and those with complete congenital hypogonadotropic hypogonadism (CCHH).This retrospective study included 587 patients with CHH who were treated in Peking Union Medical College Hospital (Beijing,China) from January 2008 to September 2016.A total of 465 cases were excluded from data analysis for testosterone or gonadotropin-releasing hormone treatment,cryptorchidism,poor compliance,or incomplete medical data.We defined male patients with PCHH as those with a testicular volume of ≥4 ml and patients with a testicular volume of <4 ml as CCHH.A total of 122 compliant,noncryptorchid patients with PCHH or CCHH received combined human chorionic gonadotropin and human menopausal gonadotropin and were monitored for 24 months.Testicular size,serum luteinizing hormone levels,follicle-stimulating hormone levels,serum total testosterone levels,and sperm count were recorded at each visit.After gonadotropin therapy,patients with PCHH had a higher spermatogenesis rate (92.3%) than did patients with CCHH (74.7%).During 24-month combined gonadotropin treatment,the PCHH group took significantly less time to begin producing sperm compared with the CCHH group (median time:11.7 vs 17.8 months,P < 0.05).In conclusion,after combined gonadotropin treatment,patients with PCHH have a higher spermatogenesis success rate and sperm concentrations and require shorter treatment periods for sperm production.
其他文献
Low-intensity extracorporeal shockwave therapy (LiESWT) represents a promising treatment for patients with erectile dysfunction (ED).We investigated the efficacy of LiESWT combined with tadalafil 5 mg once daily in men with type 2 diabetes mellitus (T2DM)
We evaluated whether the prostate-specific antigen (PSA) mass or free PSA (fPSA) mass (i.e.,absolute amount of total circulating PSA or fPSA protein,respectively),versus serum PSA or fPSA concentration,improves the accuracy of predicting the total prostat
The field of prosthetic urology demonstrates the striking impact that simple devices can have on quality of life.Penile prosthesis and artificial urinary sphincter implantation are the cornerstone procedures on which this specialty focuses.Modern research
The artificial urinary sphincter (AUS) remains the standard of care in men with severe stress urinary incontinence (SUI) following prostate surgery and radiation.While the current AUS provides an effective,safe,and durable treatment option,it is not witho
The opioid epidemic continues to be a serious public health concern.Many have pointed to prescription drug misuse as a nidus for patients to become addicted to opioids and as such,urologists and other surgical subspecialists must critically define optimal
The general practitioner (GP) is pivotally placed as an access point to provide holistic healthcare for men.GPs are the gateway to men\'s health.It is the GP who has the power to impact on the present health and ameliorate the future health of men.With
期刊
The use of artificial urinary sphincter (AUS) for the treatment of stress urinary incontinence has become more prevalent,especially in the “prostate-specific antigen (PSA)-era”,when more patients are treated for localized prostate cancer.The first widely
One of the major concerns for the prescription of medications containing testosterone (T) in the aging men with T deficiency (TD) is prostate disorders (such as benign prostatic hyperplasia,BPH) and their related symptoms (lower urinary tract symptoms,LUT
期刊
The testicular prosthesis can be an afterthought for providers when performing an orchiectomy for testicular cancer,torsion,atrophic testis,or trauma.However,data suggest that patients find the offer of a testicular prosthesis and counseling regarding pla
Testosterone (T) plays a crucial role in spermatogenesis because extremely low levels of intratesticular T lead to correspondingly low serum levels of total T (tT),severe disorders of spermatogenesis,and male sterility.However,there is little consensus on